ELIZA TANGONAN: Open Payments
NPI 1477964971 · CLARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 28 payments from 7 companies in 2025. Trend: 2023 $327 · 2024 $641 · 2025 $1,362
Food & beverage: $1,362
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $381 |
| ABBVIE INC. | 13 | $265 |
| E.R. Squibb & Sons, L.L.C. | 3 | $256 |
| REVANCE THERAPEUTICS, INC. | 1 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $112 |
| Vanda Pharmaceuticals Inc. | 5 | $79 |
Products named: Auvelity, COBENFY, DAXXIFY, VRAYLAR, BOTOX, CAPLYTA, AUSTEDO XR, FANAPT.
Industry payments across NJ — which companies pay providers there.
